A Two Part, Single-center, Randomized, Open-label, Crossover Study to Assess The Relative Bioavailability of New Tablet Formulations of GSK1265744 in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 06 Aug 2014
Price : $35 *
At a glance
- Drugs Cabotegravir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors ViiV Healthcare
- 15 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 03 May 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 07 Mar 2014 Planned End Date changed from 1 Apr 2014 to 1 Jun 2014 according to ClinicalTrials.gov record.